Accumulation of 8-n itroguanine in the liver of chronic hepatitis C patients without sustained virological response after completion of interferon therapy [2]

Journal of Gastroenterology

Volumn 41, Issue 7, 2006, Pages 713-714

  Kaito, Masahiko ^a   Horiike, Shinichiro ^a   Tanaka, Hideaki ^a   Fujita, Naoki ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 NITROGUANINE; GUANINE DERIVATIVE; INTERFERON; UNCLASSIFIED DRUG; 8-NITROGUANINE; ALPHA2B INTERFERON; ANTIVIRUS AGENT; DRUG DERIVATIVE; GUANINE;

CANCER PREVENTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; HEPATITIS C; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; VIROLOGY; CLINICAL TRIAL; CYTOLOGY; LIVER; METABOLISM; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; GUANINE; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INTERFERON ALFA-2B; LIVER; TREATMENT OUTCOME;

EID: 33747891350     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1832-z     Document Type: Letter

References (8)

1. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860-7 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D
2. SP Hussain LJ Hofseth CC Harris 2003 Radical causes of cancer Nat Rev Cancer 3 276-85 12671666 10.1038/nrc1046 1:CAS:528:DC%2BD3sXisFajtLw%3D
3. S Horiike S Kawanishi M Kaito N Ma H Tanaka N Fujita 2005 Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C J Hepatol 43 403-10 16023246 10.1016/j.jhep.2005.03.026 1:CAS:528:DC%2BD2MXntVCkurg%3D
4. S Nishiguchi T Kuroki S Nakatani H Morimoto T Takeda S Nakajima 1995 Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis Lancet 346 1051-5 7564784 10.1016/S0140-6736(95)91739-X 1:CAS:528:DyaK2MXpsl2lurY%3D
5. A Kasahara N Hayashi K Mochizuki M Takayanagi K Yoshioka S Kakumu 1998 Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group Hepatology 27 1394-402 9581697 10.1002/hep.510270529 1:CAS:528:DyaK1cXjtVSjt7Y%3D
6. K Ikeda S Saitoh Y Arase K Chayama Y Suzuki M Kobayashi 1999 Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis Hepatology 29 1124-30 10094956 10.1002/hep.510290439 1:CAS:528:DyaK1MXisVKgsLk%3D
7. Y Arase K Ikeda A Tsubota F Suzuki Y Suzuki S Saitoh 2004 Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection Intervirology 47 355-61 15564748 10.1159/000080880 1:CAS:528:DC%2BD2cXhtVagsbbF
8. M Ikeda S Fujiyama M Tanaka M Sata T Ide H Yatsuhashi 2005 Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon J Gastroenterol 40 148-56 15770398 10.1007/s00535-004-1519-2 1:CAS:528:DC%2BD2MXit1Oks7g%3D